Table 3. Evaluation of the hematologic and nutritional parameters during follow-up.
| T0 | T2 | |
|---|---|---|
| Placebo | ||
| N | 14 | 11 |
| Hemoglobin (g/dL) | 12.0±1.3 | 12.1±1.4 |
| Hematocrit (%) | 36.5±4.1 | 35.9±3.9 |
| Albumin (g/dL) | 4.1±0.2 | 4.2±0.3 |
| BMI (kg/m2) | 28.4±4.6 | 28.5±5.0 |
| WBC (mm3) | 7.271±1.576 | 7.516±1.925 |
| n-PCR (g/kg/day) | 1.09±0.20 | 1.1± 0.10 |
| Cholecalciferol | ||
| N | 18 | 12 |
| Hemoglobin (g/dL) | 11.8±1.1 | 11.6±0.7 |
| Hematocrit (%) | 35.9±3.4 | 34.9±2.8 |
| Albumin (g/dL) | 3.9±0.2 | 4.0±0.2 |
| BMI (kg/m2) | 28.6±7.4 | 28.9±7.6 |
| WBC (mm3) | 7.625±2.225 | 7.730±1.855 |
| n-PCR (g/kg/day) | 1.00±0.21 | 1.02±0.21 |
Values are expressed as the mean±standard deviation.
Abbreviations: BMI, body mass index; WBC, white blood cell; n-PCR, protein catabolic rate.
T0 = Baseline, T2 = six-month follow-up period.